PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh. rabbimedicine@bsmmu.edu.bd.\', \'Department of Blood Transfusion, Sheikh Hasina National Institute of Burn and Plastic Surgery (SHNIBPS), Dhaka, Bangladesh.\', \'Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh.\', \'Centre for Medical Biotechnology, Mohakhali, Dhaka, Bangladesh.\', \'Kuwait Bangladesh Friendship Government Hospital, Dhaka, Bangladesh.\', \'Department of Medicine, Mugda Medical College, Dhaka, Bangladesh.\', \'Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.\', \'Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-020-04734-z
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33106167
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33106167>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33106167>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all